Back to Search Start Over

Developing a quality by design approach to model tablet dissolution testing: an industrial case study

Authors :
Bernard Bataille
Ketsia Yekpe
Ryan Gosselin
Antoine Cournoyer
Nicolas Abatzoglou
Jean-Sébastien Simard
Tahmer Sharkawi
Institut Charles Gerhardt Montpellier - Institut de Chimie Moléculaire et des Matériaux de Montpellier (ICGM ICMMM)
Ecole Nationale Supérieure de Chimie de Montpellier (ENSCM)-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)-Université Montpellier 1 (UM1)-Université Montpellier 2 - Sciences et Techniques (UM2)-Institut de Chimie du CNRS (INC)
Source :
Pharmaceutical Development and Technology, Pharmaceutical Development and Technology, Taylor & Francis, 2018, 23 (6), pp.646-654. ⟨10.1080/10837450.2017.1392566⟩
Publication Year :
2018
Publisher :
HAL CCSD, 2018.

Abstract

International audience; This study applied the concept of Quality by Design (QbD) to tablet dissolution. Its goal was to propose a quality control strategy to model dissolution testing of solid oral dose products according to International Conference on Harmonization guidelines. The methodology involved the following three steps: (1) a risk analysis to identify the material- and process-related parameters impacting the critical quality attributes of dissolution testing, (2) an experimental design to evaluate the influence of design factors (attributes and parameters selected by risk analysis) on dissolution testing, and (3) an investigation of the relationship between design factors and dissolution profiles. Results show that (a) in the case studied, the two parameters impacting dissolution kinetics are active pharmaceutical ingredient particle size distributions and tablet hardness and (b) these two parameters could be monitored with PAT tools to predict dissolution profiles. Moreover, based on the results obtained, modeling dissolution is possible. The practicality and effectiveness of the QbD approach were demonstrated through this industrial case study. Implementing such an approach systematically in industrial pharmaceutical production would reduce the need for tablet dissolution testing.

Details

Language :
English
ISSN :
10837450 and 10979867
Database :
OpenAIRE
Journal :
Pharmaceutical Development and Technology, Pharmaceutical Development and Technology, Taylor & Francis, 2018, 23 (6), pp.646-654. ⟨10.1080/10837450.2017.1392566⟩
Accession number :
edsair.doi.dedup.....19034fdeb7416cc15f45ae324f526fb2
Full Text :
https://doi.org/10.1080/10837450.2017.1392566⟩